FDA Investigator Matthew M Henciak
Matthew M Henciak has conducted inspections on 35 sites in 2 countries as of 15 Mar 2010. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
35
Last Inspection Date:
15 Mar 2010
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
India
FDA Investigators that have inspected at least one site in common with Matthew M Henciak:
Alice S Tsao,
Alicia M Mozzachio,
Alison N Stieg,
Amanda B Athey,
Amy N Chen,
Angela E Glenn,
Anthony W Lee,
Arthur T Ogdahl,
Ashley L Reiber,
Ayrea V Oneal,
Barbara A Gullick,
Barbara I Rogolsky,
Bijoy Panicker,
Brooke K Higgins,
Brooke K Seeman,
Cassandra K Johnson,
Chaltu Nwakijra,
Cheryl A Clausen,
Chiang Syin, PhD,
Christina K Theodorou,
Christine M Whitby, CSO,
Christopher R Richardson,
Chryste D Best,
Clarice J Ahn,
Collins M Mason,
David A Oluwo,
David P Rice, Jr,
Devaughn Edwards,
Diane T Bargo,
Diane T O'brien,
Donald L Lech,
Douglas A Campbell,
Dr. Dominick Roselle,
Dr. Roslyn F Powers,
Dr. Yubing Tang,
Edette J Newby,
Edmund F Mrak, Jr,
Edward P Potter,
Elvis D Morton,
Emest F Bizjak,
Emmanuel A Dimaano, Jr,
Erin L Mcfiren,
Gabriel Feng,
Gale L Glinecki,
George Pyramides,
Gerald B Seaborn, Jr,
Haitao Li,
Heath R Harley,
Hector Jcolon Torres,
Helen Verdel,
Holly S Simms,
Jacqueline Johnson,
James M Mason,
James M Simpson,
Jamie D Swann,
Janete F Guardia,
Jean Blackston Hill,
Jeffrey A Reed,
Jessica D Nanini,
Joanne S Wilson,
Jogy George,
John Dan,
Johnson,
Jonah S Ufferfilge,
Jonathan W Chapman,
Jose R Hernandez,
Joseph W Matthews,
Julianne C Mccullough,
Junho Pak,
Justin A Hefferman,
Justin C Fuller,
Karen A Spencer,
Kathleen M Jordan,
Kelly Dragon,
Kenneth H Williams,
Kenneth M Gordon,
Kenneth Nieves,
Ko U Min,
Kristina L Conroy,
Laurianne M Montonye,
Lawrence Harmon, Jr,
LCDR Anastasia M Piliafas Brown,
Linda J Eason,
Lori A Holmquist,
Lori S Lawless,
LT Luis O Rodriguez,
Luis A Dasta,
Lynette P Salisbury,
Marc Balzarini,
Marc S Neubauer,
Marcellinus D Dordunoo,
Marcus A Ray,
Margaret M Doherty,
Megan A Haggerty,
Melissa J Garcia,
Merideth K Rose,
Michael A Charles,
Michael L Zimmerman,
Michael Shanks, MS,
Michelle E Noonan Smith,
Mildred L Mccray,
Mohamad A Chahine,
Myra L Gemmill,
Myra L Reed,
Natasha A Dezinna,
Nebil A Oumer,
Nicholas A Violand,
Nicholas P Schaub,
Nina D Patel,
Normica G Facey,
Patricia A Morrow,
Patrick C Klotzbuecher,
Philip W Beck,
Rachael O Oyewole,
Rachel C Harrington,
Rebecca Rodriguez,
Robert J Martin,
Rozelle G Smith,
Saleem A Akhtar,
Santos E Camara,
Sharon K Thoma, PharmD,
Shelby W Brown, Jr,
Sherry L Secrist, BLT DO,
Shirshendu K Deb, PhD,
Simone E Pitts,
Stephanie L Shapley,
Steven B Barber,
Suzanne M Healy,
Suzanne M Muchene,
Tamara N Champion,
Tania E Vizcaino,
Teresa L Fox,
Theresa M Smedley,
Tiffani D Wilson,
Tonia F Bernard,
Toyin B Oladimeji,
Valerie G Vallely,
Vani Mathur Richards,
Vesna V Stanoyevitch,
Viviana Matta,
Vivin George,
Vlada Matusovsky,
Walter L Fava,
Wanda Y Fields,
Wanda Y Honeyblue,
Wayne L Jefferson,
William H Linkroum,
Willy A Orantes,
Yvins Dezan,
Yvonne C Mcknight,
Zhongren Wu
Matthew M Henciak's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| February, 2002 | EIR | Pharmaceutics International, Inc. - EIR, 2002-02-06 |
| April, 2002 | FDA 483 Response | Actavis Mid-Atlantic, LLC. - Form 483R, 2002-05-02 |
| November, 2002 | EIR | Cipla Ltd. - EIR, 2003-01-17 |
| March, 2002 | EIR | Actavis Mid-Atlantic, LLC. - EIR, 2002-03-04 |
| January, 2002 | FDA 483 | Case-Mason Filling, Inc - Form 483, 2002-01-30 |
| March, 2002 | FDA 483 | Actavis Mid-Atlantic, LLC. - Form 483, 2002-03-04 |
| April, 2002 | FDA 483 | Actavis Mid-Atlantic, LLC. - Form 483, 2002-04-01 |
| November, 2002 | FDA 483 | Cipla Ltd. - Form 483, 2002-11-14 |
| February, 2002 | FDA 483 | Flavor & Fragrance Specialties, Inc. - Form 483, 2002-02-22 |
| October, 2001 | FDA 483 | Aerosol & Liquid Packaging, Inc. - Form 483, 2001-10-17 |
| April, 2002 | EIR | Actavis Mid-Atlantic, LLC. - EIR, 2002-04-01 |
| November, 2002 | FDA 483 Response | Cipla Ltd. - Form 483R, 2002-12-02 |
| December, 2001 | FDA 483 | PDS, Inc. - Form 483, 2001-12-05 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more